Rheumatic and Autoimmune Diseases in Minority Communities

少数民族社区的风湿病和自身免疫性疾病

基本信息

项目摘要

This project studies the clinical presentation of rheumatic diseases in an underserved, largely ethnic minority community in the Washington, DC metropolitan area. Through the NIAMS Community Health Center, subjects with rheumatic complaints are evaluated and provide clinicians with first-hand experience in understanding ethnic differences in autoimmune disease phenotypes as well as barriers to care. This project has supported research on cultural differences in understanding standardized self-report outcome assessment tools, determination of clinically important improvements in rheumatoid arthritis, use of complementary and alternative medicine in patients with rheumatic symptoms, acceptability of yoga as a treatment for arthritis by minority individuals, and understanding of the research process and informed consent among ethnic minorities. In addition, researchers have examined interventions to improve the referral process between primary care providers and subspecialists. Serological studies are currently underway to examine immune abnormalities in patients with rheumatoid arthritis and systemic lupus erythematosus.
该项目研究了华盛顿特区大都市区服务不足的主要少数民族社区风湿病的临床表现。通过NIAMS社区卫生中心,对风湿病患者进行评估,并为临床医生提供第一手经验,了解自身免疫性疾病表型的种族差异以及护理障碍。该项目支持文化差异研究,以理解标准化自我报告结果评估工具,确定类风湿关节炎的临床重要改善,在风湿性症状患者中使用补充和替代医学,少数民族个体对瑜伽作为关节炎治疗的可接受性,以及了解研究过程和少数民族的知情同意。此外,研究人员还研究了干预措施,以改善初级保健提供者和专科医生之间的转诊过程。目前正在进行血清学研究,以检查类风湿关节炎和系统性红斑狼疮患者的免疫异常。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Ward其他文献

Michael Ward的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Ward', 18)}}的其他基金

Increasing access to safe and effective products for the prevention, diagnosis and treatment of priority diseases, especially for use in low-and middle-income countries.
增加获得用于预防、诊断和治疗重点疾病的安全有效产品的机会,特别是在低收入和中等收入国家使用。
  • 批准号:
    9351278
  • 财政年份:
    2016
  • 资助金额:
    $ 37.37万
  • 项目类别:
Outcomes in Rheumatic Diseases
风湿性疾病的治疗结果
  • 批准号:
    8559298
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Outcomes in Rheumatic Diseases
风湿性疾病的治疗结果
  • 批准号:
    8939424
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Mechanisms of inherited neurodegenerative diseases
遗传性神经退行性疾病的机制
  • 批准号:
    9563182
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Mechanisms of inherited neurodegenerative diseases
遗传性神经退行性疾病的机制
  • 批准号:
    10265225
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Rheumatic and Autoimmune Diseases in Minority Communities
少数民族社区的风湿病和自身免疫性疾病
  • 批准号:
    8559307
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Outcomes in Rheumatic Diseases
风湿性疾病的治疗结果
  • 批准号:
    8746504
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Rheumatic and Autoimmune Diseases in Minority Communities
少数民族社区的风湿病和自身免疫性疾病
  • 批准号:
    9155475
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Mechanisms of inherited neurodegenerative diseases
遗传性神经退行性疾病的机制
  • 批准号:
    10708629
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:
Outcomes in Rheumatic Diseases
风湿性疾病的治疗结果
  • 批准号:
    10265851
  • 财政年份:
  • 资助金额:
    $ 37.37万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
  • 批准号:
    MR/Y009681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
  • 批准号:
    MR/Y022947/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
  • 批准号:
    10068495
  • 财政年份:
    2024
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
  • 批准号:
    24K19850
  • 财政年份:
    2024
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
  • 批准号:
    491810
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
  • 批准号:
    489316
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Operating Grants
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
  • 批准号:
    23K14987
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
  • 批准号:
    EP/Y027760/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
    Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
  • 批准号:
    10733789
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了